Debora Santini, n/a

Research Technologist
Hartford Hospital

Disclosure(s): No financial relationships to disclose

Poster(s):

• 609 - In vivo efficacy of human simulated exposures of cefiderocol (FDC) in combination with ceftazidime/avibactam (CZA) or meropenem (MEM) using in a 72 hour murine thigh infection model
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET